Global Critical Care Equipment Market Size and Forecast 2024-2033|Medtronic PLC, Boston Scientific Corporation, ThermoGenesis Holdings Inc., Abbott Laboratories, Pluri Biotech Ltd

The Critical Limb Ischemia by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Critical Limb Ischemia Market:

https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report

According to The Business Research Company’s Critical Limb Ischemia, The critical limb ischemia market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increase in diabetes cases, tobacco consumption, hypertension prevalence, improvements in vascular imaging, growth in endovascular interventions, medical research and clinical trials.

The critical limb ischemia market size is expected to see strong growth in the next few years. It will grow to $5.02 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to regenerative medicine advances, focus on early intervention, increasing prevalence of obesity, global health initiatives, patient education program.. Major trends in the forecast period include wearable health technologies, telemedicine and remote patient monitoring, integration of artificial intelligence (ai), patient-centric care models, minimally invasive interventions.

The rising incidence of diabetes mellitus and peripheral artery diseases is expected to propel the growth of the critical limb ischemia treatment market going forward. Diabetes mellitus refers to a metabolic disease condition that involves elevated levels of blood glucose. Peripheral artery disease refers to a condition where leg arteries are narrowed, reducing blood flow to the arms or legs. The likelihood of vascular complications and amputation is increased by diabetes and peripheral artery diseases, making them risk factors for causing critical limb ischemia. Therefore, the rising incidence of diabetes mellitus and peripheral artery diseases is driving the growth of the critical limb ischemia market. For instance, in January 2022, according to the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, the global diabetes prevalence in 20–79-year-olds in 2021 was 536.6 million and was expected to increase by 12.2% (783.2 million) in 2045. Furthermore, in March 2023, according to the journal published by Oxford University Press, a UK-based university press of the University of Oxford, more than 200 million people were affected by peripheral artery diseases in 2020, and it is expected to increase by nearly 50% by 2045. Therefore, the growing adoption of cloud-based document processing services is driving the critical limb ischemia treatment market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9859&type=smp

The critical limb ischemia market covered in this report is segmented –

1) By Type: Devices, Drugs, Surgery

2) By Medication: Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Other Medications

3) By Application: Hospital, Clinic, Other Applications

Technological advancements are a key trend gaining popularity in the critical limb ischemia treatment market. Major companies operating in the critical limb ischemia treatment market are adopting new technologies to strengthen their position in the market. For instance, in January 2021, the Society for Vascular Surgery (SVS), a major national academic society for vascular surgery in the United States, launched three new mobile applications related to chronic limb-threatening ischemia treatment: the VQI CLTI Mortality Prediction Model, the SVS Threatened Limb Classification [WIfI] calculator, and the Global Limb Anatomic Staging System [GLASS] calculator. They are uniquely designed applications that guide physicians in the treatment and management of chronic limb-threatening conditions, allowing real-time estimation of patient risk, the severity of limb threat, and the anatomic complexity of the disease.

The critical limb ischemia market report table of contents includes:

1. Executive Summary

2. Critical Limb Ischemia Market Characteristics

3. Critical Limb Ischemia Market Trends And Strategies

4. Critical Limb Ischemia Market – Macro Economic Scenario

5. Global Critical Limb Ischemia Market Size and Growth

26. South America Critical Limb Ischemia Market

27. Brazil Critical Limb Ischemia Market

28. Middle East Critical Limb Ischemia Market

29. Africa Critical Limb Ischemia Market

30. Critical Limb Ischemia Market Competitive Landscape And Company Profiles

Top Major Players: